The expression levels of CD44, CD90, CD133, and EpCAM were analyzed in relation to various clinicopathological variables, including tumor number (single or multiple), tumor size (<5 cm or ≥5 cm), tumor differentiation (well or moderate to poor), vascular invasion (absent or present), and cirrhosis (absent or present). This evidence concerns the gene EPCAM and Cirrhosis.